Approval Year
| Substance Class |
Structurally Diverse
Created
by
admin
on
Edited
Sat Dec 16 05:14:31 GMT 2023
by
admin
on
Sat Dec 16 05:14:31 GMT 2023
|
| Source Materials Class | ORGANISM |
| Source Materials Type | HUMAN |
| Source Materials Parent | |
| Part | BLOOD PLASMA |
| Fraction Material Type | PROTEIN |
| Fraction Name | IGG |
| Record UNII |
9LKK68BOP0
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
FDA ORPHAN DRUG |
144501
Created by
admin on Sat Dec 16 05:14:31 GMT 2023 , Edited by admin on Sat Dec 16 05:14:31 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
9LKK68BOP0
Created by
admin on Sat Dec 16 05:14:31 GMT 2023 , Edited by admin on Sat Dec 16 05:14:31 GMT 2023
|
PRIMARY |
Agent Modifications
| Modification Process | Modification Role | Modification Type | Amount | Fragment Name | Fragment ID |
|---|---|---|---|---|---|
| DONOR SELECTED | TARGETED ANTIGENS | IMMUNOLOGICAL |
|
UNSPECIFIED SUBSTANCE | 7724a336 |
| DONOR SELECTED | TARGETED ANTIGENS | IMMUNOLOGICAL |
|
UNSPECIFIED SUBSTANCE | cf1b8c2e |